Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Weak PR

Re: Weak PR.. Soph

posted on Mar 08, 2007 07:50AM

It is a leap of faith on my part... but seeing the warrant numbers (prev 10Ks & Qs) that S&L once held.. over 100 mil (120m?) in the not so distant past.. and seeing that their holdings as of Nov of '06 were under 30 mil... I have jumped to the conclusion that S&L have been converting warrants.. and to stay under the 9.99% cap they have, they must concurrently sell nearly the exact number of held shares.

And as per Hawk's response to patientman (IMO confirmation) .. if PTSC does not want to be viewed as a P&D.... someone must be D-ing... cuz we know PTSC ain't P-ing

Share
New Message
Please login to post a reply